Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME
Clinical trial NCT02262260 · COMPLETED
Trial details
- NCT number
- NCT02262260
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-12
- Primary completion
- 2017-09-12
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.